Serum levels of nitrite/nitrate, lipid profile, and Fasting Plasma Glucose and their associations in subclinical hypothyroid women before and after a two month treatment by levothyroxine

1. TADDEI S, CARACCIO N, VIRDIS A, DARDANO A, VERSARI D, GHIADONI L, et al. Impaired endothelium-dependent vasodilatation in subclinical hypothyroidism: beneficial effect of levothyroxine therapy. J Clin Endocrinol Metab. 2003; 88: 3731-3737.10.1210/jc.2003-03003912915662Search in Google Scholar

2. CANARIS GJ, MANOWITZ NR, MAYOR G, RIDGWAY EC. The Colorado thyroid disease prevalence study. Arch Intern Med. 2000; 160:526-34.10.1001/archinte.160.4.52610695693Search in Google Scholar

3. UPADYA UB, SUMA MN, SRINATH KM, PRASHANT A, DODDAMANI P, SHILPA SV, et al. Effect of insulin resistance in assessing the clinical outcome of clinical and subclinical hypothyroid patients. Journal of clinical and diagnostic research: JCDR. 2015; 9(2): OC01-. OC04.Search in Google Scholar

4. MAZAHERI T, SHARIFI F, KAMALI K. Insulin resistance in hypothyroid patients under Levothyroxine therapy: a comparison between those with and without thyroid autoimmunity. Journal of Diabetes & Metabolic Disorders. 2014; 13(1): 103.10.1186/s40200-014-0103-4421665625364704Search in Google Scholar

5. PEPPA M, KOLIAKI C, NIKOLOPOULOS P, RAPTIS SA. Skeletal muscle insulin resistance in endocrine disease. Journal of Biomedicine and Biotechnology 2010. Article ID 527850.10.1155/2010/527850284041320300436Search in Google Scholar

6. SINGH BM, GOSWAMI B, MALLIKA V. Association between insulin resistance and hypothyroidism in females attending a tertiary care hospital. Indian Journal of Clinical Biochemistry. 2010; 25 (2): 141-145.10.1007/s12291-010-0026-x345309723105900Open DOISearch in Google Scholar

7. CHUBB SA, DAVIS WA, DAVIS TM. Interactions among thyroid function, insulin sensitivity, and serum lipid concentrations: the Fremantle diabetes study. J Clin Endocrinol Metab. 2005; 90: 5317-20.10.1210/jc.2005-029815985488Open DOISearch in Google Scholar

8. LADENSON PW, SINGER PA, AIN KB, BAGCHI N, BIGOS ST, LEVY EG, et al. American Thyroid Association guidelines for detection of thyroid dysfunction. Arch Intern Med. 2000; 160: 1573–1575.10.1001/archinte.160.11.157310847249Search in Google Scholar

9. ASVOLD BO, VATTEN LJ, NILSEN TI, BJORO T. The association between TSH within the reference range and serum lipid concentrations in a population-based study. The HUNT Study. Eur J Endocrinol. 2007; 156: 181-6.Search in Google Scholar

10. PEARCE EN, WILSON PW, YANGY Q, VASAN RS, BRAVERMAN LE. Thyroid function and lipid subparticle sizes in patients with short term hypothyroidism and a population-based cohort. J Clin Endocrinol Metab. 2008; 93: 888-94.10.1210/jc.2007-1987226694618073305Search in Google Scholar

11. ÇATLI G, ANIK A, ÜNVER TUHAN H, BOBER E, ABACT A. The effect of L-thyroxine treatment on hypothyroid symptom scores and lipid profile in children with subclinical hypothyroidism. J Clin Res Pediatr Endocrinol. 2014; 6: 238-244.10.4274/jcrpe.1594429365925541895Search in Google Scholar

12. MUTLU S, PARLAK A, AYDOGAN U, AYDOGDU A, SOYKUT B, AKAY C, et al. The effect of levothyroxine replacement therapy on lipid profile and oxidative stress parameters in patients with subclinical hypothyroid. Archives of pharmacal research. 2013; 1-9.10.1007/s12272-013-0227-y23925559Search in Google Scholar

13. BAMASHMOOS SA, AL-NUZAILY MAK, AL-MEERI AM, ALI FHH. Relationship between total homocysteine, total cholesterol and creatinine levels in overt hypothyroid patients. SpringerPlus. 2013; 2: 423.10.1186/2193-1801-2-423376650724024107Search in Google Scholar

14. DAGRE AG, LEKAKIS JP, PAPAIOANNOU TG, PAPAMICHAEL CM, KOUTRAS DA, STAMATELOPOULOS SF, et al. Arterial stiffness is increased in subjects with hypothyroidism. Int J Cardiol. 2005; 103: 1-6.10.1016/j.ijcard.2004.05.06816061115Search in Google Scholar

15. OBRADOVIC M, GLUVIC Z, SUDAR-MILOVANOVIC E, PANIC A, TREBALJEVAC J, BAJIC V, et al. Nitric oxide as a marker for levo-thyroxine therapy in subclinical hypothyroid patients. Curr Vasc Pharmacol. 2016; 14(3): 266-70.10.2174/157016111466616020814353726853795Open DOISearch in Google Scholar

16. DAGRE AG, LEKAKIS JP, PROTOGRON AD. Abnormal endothelial function in female patients with hypothyroidism and borderline thyroid function. Int J Cardiol. 2007; 114: 332–338.10.1016/j.ijcard.2005.12.01316793150Search in Google Scholar

17. QUESADA A, SAINZ J, WANGSTEEN R, RODRIGUEZ-GOMEZ I, VARGAS F, OSUNA A. Nitric oxide synthase activity in hyperthyroid and hypothyroid rats. European Journal of Endocrinology. 2002; 147(1): 117-122.10.1530/eje.0.147011712088928Search in Google Scholar

18. 18. BRADLEY SE, STEPHAN F, COELHO JB, REVILLE P. The thyroid and the kidney. Kidney international. 1974; 6(5): 346-365.10.1038/ki.1974.1194431166Open DOISearch in Google Scholar

19. KLEIN I, OJAMAA K. Thyroid hormone and the cardiovascular system. New England Journal of Medicine. 2001; 344(7): 501-509.10.1056/NEJM20010215344070711172193Search in Google Scholar

20. DANZI S, KLEIN I. Thyroid hormone and blood pressure regulation. Curr Hypertens Rep. 2003; 5:513-20.10.1007/s11906-003-0060-714594573Open DOISearch in Google Scholar

21. BASKIN HJ, COBIN RH, DUICK DS, GHARIB H, GUTTLER RB, KAPLAN MM, et al. American Association of Clinical Endocrinologists medical guidelines for clinical practice for the evaluation and treatment of hyperthyroidism and hypothyroidism. Endocr Pract. 2002; 8:457-469.10.4158/1934-2403-8.6.45727762623Search in Google Scholar

22. RAMSEY MW, GOODFELLOW J, JONES CJH, LUDDINTON LA, LEWIS MJ, HENDERSON AH. Endothelial control of arterial distensibility is impaired in chronic heart failure. Circulation. 1995; 92: 3212-3219.10.1161/01.CIR.92.11.32127586306Open DOISearch in Google Scholar

23. HUSSEIN WI, GREEN R, JACOBSEN DW, FAMAN C. Normalization of hyperhomocysteinemia with L-thyroxine in hypothyroidism. Annals of internal medicine. 1999; 131(5): 348-351.10.7326/0003-4819-131-5-199909070-0000510475887Search in Google Scholar

24. FICHTLSCHERER S, ROSENBERGER G, WALTER DH, BREUER S, DIMMELER S, ZEIHER AM. Elevated C-reactive protein levels and impaired endothelial vasoreactivity in patients with coronary artery disease. Circulation. 2000; 102: 1000-1006.10.1161/01.CIR.102.9.1000Open DOISearch in Google Scholar

25. SELLITTI DF, DENISSON D, AKAMIZU T, DOI SQ, KOHN LD, KOSHIYAMA H. Thyrotropin regulation of cyclic adenosine monophosphate production in human coronary artery smooth muscle cells. Thyroid. 2000; 10: 219-225.10.1089/thy.2000.10.21910779136Search in Google Scholar

26. PAPAIOANNOU GI, LAGASSE M, MATHER JF, THOMPSON PD. Treating hypothyroidism improves endothelial function. Metabolism. 2004; 53: 278-9.10.1016/j.metabol.2003.10.00315015136Search in Google Scholar

27. CAPPOLA AR, LADENSON PW. Hypothyroidism and atherosclerosis. The Journal of Clinical Endocrinology & Metabolism. 2003; 88(6): 2438-2444.10.1210/jc.2003-03039812788839Open DOISearch in Google Scholar

28. NESS GC, CHAMBERS CM. Feedback and hormonal regulation of hepatic 3-hydroxy-3-methylglutaryl coenzyme A reductase: the concept of cholesterol buffering capacity, Proc. Soc. Exp. Biol. Med. 2000; 224: 8-19.Search in Google Scholar

29. SHIN DJ, OSBORNE TF. Thyroid hormone regulation and cholesterol metabolism are connected through Sterol Regulatory Element Binding Protein-2 (SREBP-2). J Biol Chem. 2003; 278: 34114-8.10.1074/jbc.M30541720012829694Search in Google Scholar

30. HUUSKONEN J, VISHNU M, PULLINGER CR, FIELDING PE, FIELDING CJ. Regulation of ATP-binding cassette transporter A1 transcription by thyroid hormone receptor. Biochem. 2004; 43(6): 1626-1632.10.1021/bi030164314769039Search in Google Scholar

31. GOLDSTEIN JL, DEBOSE-BOYD RA, BROWN MS. Protein sensors for membrane sterols. Cell. 2006; 124(1): 35-46.10.1016/j.cell.2005.12.02216413480Search in Google Scholar

32. HASHIMOTO K, COHEN RN, YAMADA M, MARKAN KR, MONDEN T, SATOH T, et al. Cross-talk between thyroid hormone receptor and liver X receptor regulatory pathways is revealed in a thyroid hormone resistance mouse model. Journal of Biological Chemistry. 2006; 281(1): 295-302.10.1074/jbc.M50787720016260782Search in Google Scholar

33. LOPEZ D, ABISAMBRA SOCARRAS JF, BEDI M, NESS GC. Activation of the hepatic LDL receptor 703 promoter by thyroid hormone. Biochim Biophys Acta. 2007; 1771: 1216-1225.10.1016/j.bbalip.2007.05.00117572141Search in Google Scholar

34. JIN T, TENG X. Update on Lipid Metabolism and Thyroid Disorders. J Endocrinol Diabetes Obes. 2014; 2(3): 1043.Search in Google Scholar

35. BANSAL SK, YADAV R. A Study of the Extended Lipid Profile including Oxidized LDL, Small Dense LDL, Lipoprotein (a) and Apolipoproteins in the Assessment of Cardiovascular Risk in Hypothyroid Patients. Journal of clinical and diagnostic research: JCDR. 2016; 10(6): BC04.10.7860/JCDR/2016/19775.8067496363627504276Search in Google Scholar

36. JUNG CH, SUNG KC, SHIN HS, RHEE EJ, LEE WY, KIM BS, et al. Thyroid dysfunction and their relation to cardiovascular risk factors such as lipid profile, hsCRP, and waist hip ratio in Korea. Korean J Intern Med. 2003; 18: 146-53.10.3904/kjim.2003.18.3.146453163014619383Open DOISearch in Google Scholar

37. DUMAN D, SAHIN S, ESERTAS K, DEMIRTUNC R. Simvastatin improves endothelial function in patents with subclinical hypothyroidism. Heart Vessels. 2007; 22: 88-93.10.1007/s00380-006-0950-017390202Open DOISearch in Google Scholar

38. RIZOS C, ELISAF MS, LIBEROPOULOS EN. Effects of thyroid dysfunction on lipid profile. Open Cardiovascular Medicine Journal. 2011; 5: 76-84.10.2174/1874192401105010076310952721660244Search in Google Scholar

39. AL-TONSI AA, ABDEL-GAYOUM AA, SAAD M. The secondary dyslipidemia and deranged serum phosphate concentration in thyroid disorders. Exp Mol Pathol. 2004; 76: 182-7.10.1016/j.yexmp.2003.10.00615010297Search in Google Scholar

40. TEIXEIRA Pde F, REUTERS VS, FERREIRA MM, ALMEIDA CP, REIS FAA, BUESCU A, et al. Lipid profile in different degrees of hypothyroidism and effects of levothyroxine replacement in mild thyroid failure. Transl Res. 2008; 151: 224-31.10.1016/j.trsl.2007.12.00618355770Search in Google Scholar

41. MARWAHA R, TANDON N, GARG M, KANWAR R, SASTRY A, NARANG A, et al. Dyslipidemia in subclinical hypothyroidism in an Indian population. Clin Biochem. 2011; 44(14-15): 1214-1217.10.1016/j.clinbiochem.2011.07.00321782807Open DOISearch in Google Scholar

42. BOELAERT K, FRANKLYN J. Thyroid hormone in health and disease. Journal of Endocrinology. 2005; 187(1): 1-15.10.1677/joe.1.0613116214936Search in Google Scholar

43. RIFAI N, WARNICK GR. Lipids, lipoproteins, apolipoproteins, and other cardiovascular risk factors. In: Burtis CA, Ashwood ER, Bruns DE, eds. Tietz Textbook of Clinical Chemistry and Molecular Diagnostics. 4th ed. Philadelphia, Pa: Elsevier Saunders; 2006: 903–982.Search in Google Scholar

44. MARATOU E, HADJIDAKIS DJ, KOLLIAS A, TSEGKA K, PEPPA M, ALEVIZAKI M, et al. Studies of insulin resistance in patients with clinical and subclinical hypothyroidism. Eur J Endocrinol. 2009; 160: 785-90.10.1530/EJE-08-079719141606Search in Google Scholar